NIH #5R37CA296642-02
Dysregulated Complement Pathway in Macrophage Reprogramming and Progression of HCC in MASH
- Amount
- $601K
- Period
- 2024-12-10 → 2029-11-30
- PIs
- 1
- Est. capacity / PI
- ~6 students
Hepatocellular Carcinoma Treatment and Prognosis · Hepatology
7 total · 2 active
NIH #5R37CA296642-02
NIH #1R37CA296642-01
NIH #5K08CA222676-05
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-10
Unraveling the tapestry: Lessons from multi-omics and spatial biology in hepatocellular cancer
Hepatology · 2026-02-12
Modeling patient tissues at molecular resolution with EvaPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-12
Nature · 2025-11-27
2025-11-24
2025-11-24
American Journal of Roentgenology · 2025-08-20 · 2 citations
UNC Libraries · 2025-07-09
UNC Libraries · 2025-06-28
UNC Libraries · 2025-06-26
The Immune Microenvironment of Transplant Glomerulitis
Kidney International Reports · 2025-06-18 · 1 citations
Redefining cancer care: the case for an onco-gastroenterology subspecialty
Nature Reviews Gastroenterology & Hepatology · 2025-05-23
Practical approach to diagnose and manage benign liver masses
Hepatology Communications · 2024-10-29 · 11 citations
Nature Cancer · 2024-09-20 · 44 citations